Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Person on a laptop using Fox Trial Finder.

    Ways to Advance Parkinson’s Research Online During COVID-19

    While some clinical trials have paused, there are still opportunities to contribute and advance Parkinson’s research from home.
    Learn more

  • A Note from Our CEO: Partnerships Foster Progress

    Our CEO on the Importance of Partnerships in Drug Research

    Our CEO Todd Sherer talks to the Foundation for the National Institutes of Health (FNIH) about the Accelerating Medicines Partnership for Parkinson’s Disease (AMP PD).
    Learn more

  • New Collaboration Seeks to Incorporate Patient Feedback into Clinical Trials

    News in Context: The PASADENA Study

    We talk to representatives from Roche and Prothena about the results of the PASADENA clinical trial of a potential Parkinson's therapy targeting alpha-synuclein.
    Learn more

  • Beakers lined up.

    Newly Approved Parkinson’s Drug Aims to Lessen “Off” Time

    The FDA approved a new Parkinson’s medication that works with levodopa to give better symptom control and less “off” time throughout the day.
    Learn more

  • Well plate

    What We Fund: $10.4 Million in New Grants for Parkinson’s Research

    Our new grants include projects across our strategy to define, measure and treat Parkinson's disease.
    Learn more

  • Fox Insight on an iPad.

    New Survey on the Impact of COVID-19 In MJFF’s Online Study, Fox Insight

    Our online study, Fox Insight, has a survey open now that aims to understand the impact of COVID-19 on the Parkinson’s community. Join today at foxinsight.org to share your experience and help inform…
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.